No way it is a soft launch this time around. Some comments from recent announcements and reports:. If you're ever feeling swayed by the constant negativity of some, just refer back to May's Presentation and concentrate on the following:
First licensing revenues underway & expected to build through 2017
OBJ expects increasing revenue based upon P&G’s revenue guidance
Licensed products (microarray) now being distributed by P&G
Two additional microarray products licensed to P&G ready for distribution, two more under development Second technology licensed to P&G & expected to be commercialised over next 18 months
Successful Bodyguard clinical trial completed at UQ – Japanese manufacturer engaged. Distribution discussions with three parties in different markets/market segments
Two Accelerators in discussions to fund OBJ’s technologies in conjunction with P&G
I don't know of too many R&D companies on the ASX with so much on their plate and within months of significant on-going revenues.
- Forums
- ASX - By Stock
- Another soft launch
No way it is a soft launch this time around. Some comments from...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online